Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillation.

BACKGROUND: Age is an independent risk factor for thromboembolism in nonvalvular atrial fibrillation (NVAF). An association between low left atrial appendage (LAA) Doppler velocities and thromboembolic risk in NVAF has been reported. HYPOTHESIS: The study was undertaken to identify age-related differences in LAA function that may explain the higher thromboembolic rates in older patients with NVAF. METHODS: Forty-two consecutive patients (age 69+/-2 years [range 42-92], 24 [57%] men) with NVAF underwent transthoracic and transesophageal echocardiography. The following were compared in 22 patients younger and 20 older than 70 years: left ventricular (LV) diameter, mass and ejection fraction, left atrial (LA) diameter and volume, LAA area and volume, LAA peak emptying (PE) and peak filling (PF) velocities, presence and severity of spontaneous echo contrast (SEC) and mitral regurgitation (MR). RESULTS: Left atrial diameter (4.6+/-0.1 vs. 4.5+/-0.2 cm), LA volume (105+/-10 vs. 92+/-8 ml), LAA area (6.8+/-0.6 vs. 5.2+/-0.8 cm2), and LAA volume (5.6+/-0.9 vs. 3.9+/-1.0 ml) were similar (p>0.05) in both groups. Older patients had lower LAA PE (26+/-2 vs. 34+/-3 cm/s, p = 0.02) and PF (32+/-2 vs. 41+/-4 cm/s, p = 0.04) velocities, lower LV mass (175+/-13 vs. 234+/-21 gm, p = 0.02), higher relative wall thickness (0.52+/-0.02 vs. 0.43+/-0.03, p = 0.02), smaller LV diastolic diameter (4.3+/-0.1 vs. 5.2+/-0.2 cm, p < 0.001), and higher LV ejection fraction (62+/-2 vs. 55+/-2%, p = 0.025). Frequency and severity of SEC and MR were similar in both groups. Multivariate analysis identified older age as the only significant predictor of reduced LAA velocities. CONCLUSION: Compared with younger patients, older patients with NVAF have lower LAA velocities despite higher LV ejection fraction, smaller LV size, and similar LA and LAA volumes. These findings may explain the higher thromboembolic rates in older patients with NVAF.

Simultaneous Doppler/catheter measurements of pressure gradients in aortic valve disease: a correction to the Bernoulli equation based on velocity decay in the stenotic jet.

BACKGROUND AND AIM OF THE STUDY: Characterization of the severity of a stenotic aortic valve relies on accurate measurement of the pressure drop across the valve. A simplified form of the Bernoulli equation has been used to estimate pressure drops using Doppler ultrasound, but these measurements often overestimate gold standard measurements performed during cardiac catheterization. Sources of discrepancy between the Doppler and catheter measurements have been identified, but no method has been developed to fully reconcile the two techniques. METHODS: In this study we developed a correction to the clinical form of the Bernoulli equation based on receiving chamber geometry and turbulent jet profiles. The theoretical treatment of the mechanical energy balance, assuming a shape to the stenotic jet profile is described, and the assumptions in our model are discussed. The use of the model was then demonstrated in an in vivo clinical study in which simultaneous Doppler and catheter data were obtained. RESULTS: Discrepancies between Doppler and catheter are shown to be a function of the predicted pressure recovery location based on our assumed profile. There exists a distance of about 8.67 valve radii downstream where agreement in peak pressure gradients is theoretically achieved. CONCLUSION: The results demonstrate the ability to characterize pressure recovery distal to the valve. Our approach, to substitute a more appropriate velocity profile into the mechanical energy balance, unifies geometric parameters and the physics of turbulent jet flow in an equation involving quantities already routinely measured in an echocardiographic examination of aortic stenosis. This allows for both the maximal and recovered pressure gradient to be obtained from the Doppler data. These results have implications for optimal pressure sensor placement for the assessment of aortic stenosis and also for the evaluation of prosthetic heart valves in vitro.

Clinical significance of fossa ovalis membrane aneurysm in adults with cardioembolic cerebral ischemia.

Fossa ovalis membrane aneurysm was diagnosed by transesophageal echocardiography in 45 of 134 consecutive patients (34%) with embolic cerebrovascular ischemic events. A potential cardiovascular source of embolism, other than the fossa ovalis membrane aneurysm, was found in 91% of these patients (41 of 45).

Characterization of collagen by high-frequency ultrasound: evidence for different acoustic properties based on collagen fiber morphologic characteristics.

Fibrous tissue on conventional ultrasound images appears as an echo-bright area. We have observed that on high-frequency ultrasonography images of thin sections of myocardium, fibrous tissue may appear as either a dark or light area. This study was designed to test the hypothesis that echo characteristics of fibrous tissue on high-frequency ultrasonography are determined by collagen fiber morphologic characteristics. We examined 16 tissue specimens from human beings and rats containing different forms of fibrosis. The specimens were sectioned at 5 microns, placed on a glass slide, and imaged with a 600 MHz transducer. On ultrasound images, collagen appeared either as a dark amorphous area or a light area that had a fibrillar pattern. The same specimens were then stained with picrosirius red and examined with polarized light. When viewed with polarized light microscopy, thick collagen fibers appear red or orange and thin fibers appear green or yellow. Polarized light microscopy revealed that dark areas on ultrasound images corresponded to thick collagen fibers that were predominantly longitudinally sectioned. In contrast, light areas corresponded to regions of thin, loosely packed fibers, or to thick collagen fibers that were obliquely sectioned. Collagen has different appearances on high-frequency ultrasound images depending on collagen fiber morphologic characteristics. If such variation in echo intensity also occurs with lower frequency transducers used in clinical echocardiography, the differentiation between normal myocardium and immature scar may be difficult.

Transesophageal assessment of coronary flow velocity reserve during "regular" and "high"-dose dipyridamole stress testing.

To assess the effect of regular and high-dose dipyridamole on coronary flow velocity in the left anterior descending artery (LAD), and to determine whether assessment of coronary flow velocity reserve (CFVR) is more sensitive for detection of ischemia than standard echocardiographic criteria, 47 patients were studied prospectively: 16 patients with stenosis of the LAD, 18 patients with angiographically normal LADs, and 13 patients with minimal disease. Patients underwent transesophageal echocardiographic study of wall motion and LAD flow velocity at baseline and at hyperemia, and for angina and electrocardiographic changes. The mean CFVR values after 0.56 mg/kg after 0.84 mg/kg of dipyridamole were similar: 2.52 +/- 0.87 versus 2.62 +/- 0.90. A CFVR <2.3 (normals mean -2 SDs) was more sensitive (88% at both doses) for the detection of underlying coronary obstruction than was wall motion monitoring (44% and 75%, respectively). The combination of CFVR <2.3 and wall monitoring was more sensitive than index alone (94% at both 0.56 and 0.84 mg/kg). The rate-pressure product was not significantly different at the two doses of dipyridamole. When flow response is the end point of stress testing, as with transesophageal monitoring, the 0.56 mg/kg dose of dipyrid mole is adequate, but when ischemia is the end point (as with wall motion monitoring by 2-dimensional echocardiography), the dose of 0.84 mg/kg is more sensitive.